Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function

High serum levels of interleukin‐6 (IL‐6) correlate with poor prognosis and chemotherapy resistance in several cancers. The underlying mechanisms and its effects on immunotherapy are largely unknown. To address this, we developed a human papillomavirus type 16 (HPV16)‐associated tumor model expressi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Cancer
Huvudupphovsmän: Beyranvand Nejad, Elham, Labrie, Camilla, van der Sluis, Tetje C., van Duikeren, Suzanne, Franken, Kees L. M. C., Roosenhoff, Rueshandra, Arens, Ramon, van Hall, Thorbald, van der Burg, Sjoerd H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2020
Ämnen:
Tumor Immunology and Microenvironment
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693233/
https://ncbi.nlm.nih.gov/pubmed/32875568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33280
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk